LFG
RIGL icon

Larson Financial Group’s Rigel Pharmaceuticals RIGL Stock Holding History

Larson Financial Group’s Portfolio RIGL Stock Details RIGL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.19K Buy
44
+39
+780% +$1.31K ﹤0.01% 3101
2025
Q4 		$214 Buy
+5
New +$188 ﹤0.01% 3263

Other funds holding RIGL

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Larson Financial Group's RIGL Position: Q1 2026 in Review

Larson Financial Group increased its Rigel Pharmaceuticals (RIGL) stake by 780% in Q1 2026, buying an estimated $1.31K and bringing the position to 44 shares worth $1.19K. The position accounts for ﹤0.01% of the portfolio, ranked #3101.

Larson Financial Group first reported a position in RIGL in Q4 2025 and has held it in 2 quarters since. 159 funds tracked by Wall St. Rank hold RIGL as of Q1 2026.

  • Larson Financial Group held 44 shares of Rigel Pharmaceuticals worth $1.19K as of Q1 2026.
  • Larson Financial Group bought 39 Rigel Pharmaceuticals shares in Q1 2026, an estimated $1.31K.
  • Rigel Pharmaceuticals made up ﹤0.01% of Larson Financial Group's portfolio in Q1 2026, its #3101 holding.
  • Larson Financial Group first reported a position in Rigel Pharmaceuticals in Q4 2025 and has held it in 2 quarters since.
  • 159 funds tracked by Wall St. Rank held Rigel Pharmaceuticals as of Q1 2026.

Based on Larson Financial Group's 13F filing for Q1 2026, filed 15 May 2026.